Graphic Packaging
GPK
$10.65
-3.79%
Graphic Packaging Holding Company is a leading manufacturer of paper-based consumer packaging products, operating primarily in the Americas, Europe, and Asia Pacific within the Packaging & Containers industry. The company is a significant player in the paperboard packaging market, serving consumer packaged goods companies and foodservice sectors with products like cups, lids, and food containers. The current investor narrative revolves around navigating a challenging demand environment and significant margin compression, as evidenced by recent sharp declines in profitability and stock price, raising questions about the company's near-term earnings recovery and operational efficiency.…
GPK
Graphic Packaging
$10.65
GPK 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Graphic Packaging's 12-month outlook, with a consensus price target around $13.85 and implied upside of +30.1% versus the current price.
Average Target
$13.85
2 analysts
Implied Upside
+30.1%
vs. current price
Analyst Count
2
covering this stock
Price Range
$9 - $14
Analyst target range
Analyst coverage is extremely limited, with only 2 analysts providing estimates, indicating this is a under-followed mid-cap stock where limited institutional interest can lead to higher volatility and less efficient price discovery. The available data shows estimated EPS for the next period has a range from $1.86 to $1.93, with an average of $1.90, and estimated revenue averages $9.03 billion, but no consensus price target or recommendation distribution is provided in the data, preventing a calculation of implied upside or downside. The recent institutional rating actions from firms like Wells Fargo and Baird show a pattern of downgrades to 'Underweight' and 'Neutral' in early 2026, reflecting a bearish shift in sentiment following disappointing financial results; this lack of bullish coverage and the downgrade trend further underscores the challenging near-term outlook and high uncertainty surrounding the stock.
Bulls vs Bears: GPK Investment Factors
The bear case currently holds stronger evidence, anchored by the severe and recent deterioration in profitability and revenue trends. The bull case rests primarily on a deep valuation discount and the potential for a cyclical recovery, but this is a hope-based thesis lacking near-term catalysts. The single most important tension in the investment debate is whether the dramatic margin compression (gross margin down 780 bps YoY) is a temporary, cyclical issue or a permanent impairment of the company's pricing power and cost structure. The resolution of this margin question will determine if the stock is a deep-value opportunity or a value trap.
Bullish
- Deeply Undervalued Multiples: The stock trades at a trailing P/E of 10.06x and a forward P/E of 9.61x, a significant discount to the historical sector average in the mid-teens. Its EV/EBITDA of 7.29x and P/S of 0.52x further indicate a material valuation discount, suggesting the market has priced in severe pessimism.
- Strong Recent Technical Bounce: The stock has rallied 17.3% over the past month from deeply oversold levels near its 52-week low of $8.79. This bounce, while not yet a trend reversal, suggests potential mean reversion after a -49.5% one-year decline, with the price now 15% above its 52-week low.
- Stable Balance Sheet & Dividend: The company maintains a manageable debt-to-equity ratio of 1.67 and a current ratio of 1.30. It also pays a dividend with a 28.8% payout ratio and a 2.9% yield, providing some income support and signaling financial stability despite operational headwinds.
- Analyst EPS Estimates Suggest Recovery: The average analyst EPS estimate for the next period is $1.90, which is significantly higher than the most recent quarterly EPS of $0.24. This implies expectations for a meaningful earnings recovery, which, if achieved, would justify a higher share price given the low forward P/E.
Bearish
- Severe Profitability Collapse: Gross margin collapsed to 14.4% in Q4 2025 from 22.1% a year earlier, and net income fell 49% YoY to $71 million. This dramatic margin compression, with TTM net margin at 5.15%, indicates a severe loss of pricing power and operational efficiency.
- Revenue Stagnation & Sequential Decline: Q4 2025 revenue grew a mere 0.38% YoY and declined sequentially from $2.19B in Q3 to $2.10B. This flat-to-declining top-line trend, coupled with a multi-quarter downtrend from 2024 peaks, signals fundamental demand weakness and destocking in its end markets.
- Negative Free Cash Flow & Analyst Downgrades: Trailing twelve-month free cash flow is negative $81 million, indicating the company is consuming cash. This is compounded by recent analyst downgrades to 'Underweight' and 'Neutral' in early 2026, reflecting a bearish shift in institutional sentiment following poor results.
- Persistent Downtrend & Underperformance: The stock is down 49.5% over the past year, underperforming the S&P 500 by over 77 percentage points. Despite the recent bounce, the dominant trend remains negative, with the stock still down 7.9% over the last three months, suggesting the rally may be a bear market bounce.
GPK Technical Analysis
The stock is in a pronounced and sustained downtrend, with a 1-year price change of -49.5%, significantly underperforming the S&P 500's +28.2% gain. Currently trading at $11.26, the price sits near the lower end of its 52-week range of $8.79 to $23.76, positioning it at approximately 15% of the range's span, which suggests the stock is deeply oversold and may present a value opportunity, though it also risks being a 'falling knife' amid persistent negative momentum. Recent momentum shows a sharp divergence, with a strong 1-month rally of +17.3% contrasting the severe 3-month decline of -7.9%; this recent bounce, occurring from deeply oversold levels near the 52-week low, could signal a potential short-term mean reversion or a bear market rally, but it has yet to challenge the dominant downtrend. Key technical support is firmly established at the 52-week low of $8.79, while resistance looms at the 52-week high of $23.76; a sustained breakout above recent highs near $12 would be needed to signal a potential trend reversal, while a breakdown below $8.79 could trigger another leg down. With a beta of 0.62, the stock has exhibited about 38% less volatility than the broader market, which is unusual for a stock in such a steep decline and may indicate it is being treated as a defensive or low-beta industrial, impacting potential risk/reward calculations for traders.
Beta
0.67
0.67x market volatility
Max Drawdown
-62.2%
Largest decline past year
52-Week Range
$9-$24
Price range past year
Annual Return
-49.8%
Cumulative gain past year
| Period | GPK Return | S&P 500 |
|---|---|---|
| 1m | +10.5% | +0.3% |
| 3m | +13.8% | +12.3% |
| 6m | -31.0% | +8.9% |
| 1y | -49.8% | +24.0% |
| ytd | -29.7% | +8.7% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
GPK Fundamental Analysis
Revenue growth has stagnated and turned negative on a sequential basis, with Q4 2025 revenue of $2.10 billion representing a mere 0.38% year-over-year increase and a decline from the $2.19 billion reported in Q3 2025; this flat trajectory, coupled with a multi-quarter trend of declining sales from peaks in 2024, indicates the company is facing significant top-line pressure, likely from weak consumer demand and destocking in its end markets. Profitability has deteriorated sharply, with Q4 2025 net income of $71 million and a gross margin of 14.4%, down significantly from the $138 million net income and 22.1% gross margin in Q4 2024; this severe margin compression, evident in the trailing twelve-month net margin of 5.15%, points to intense cost inflation and an inability to pass on price increases, raising concerns about the company's pricing power and operational efficiency. The balance sheet shows moderate financial health with a current ratio of 1.30 and a debt-to-equity ratio of 1.67, indicating manageable but elevated leverage; however, the trailing twelve-month free cash flow is negative $81 million, and the most recent quarterly operating cash flow was $534 million against capital expenditures of $127 million, suggesting the company can fund its operations but has limited internal cash generation for growth or debt reduction after accounting for its dividend payout ratio of 28.8%.
Quarterly Revenue
$2.1B
2025-12
Revenue YoY Growth
+0.00%
YoY Comparison
Gross Margin
+0.14%
Latest Quarter
Free Cash Flow
$-81000000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is GPK Overvalued?
Given a positive net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. The stock trades at a trailing PE of 10.06x and a forward PE of 9.61x based on estimated EPS; the minimal gap between trailing and forward multiples suggests the market has very low expectations for near-term earnings growth or improvement. Compared to sector averages, the valuation appears discounted; for instance, the trailing PE of ~10x is significantly below the historical sector average often seen in the mid-teens for packaging companies, and the Price-to-Sales ratio of 0.52x and EV/EBITDA of 7.29x also suggest a material discount, which may be justified given the company's recent profitability collapse and uncertain growth outlook. Historically, the current trailing PE of 10.06x is near the bottom of its own multi-year range, as evidenced by historical PE ratios that were above 15x for much of 2024 and early 2025; trading at these depressed historical levels suggests the market is pricing in significant fundamental deterioration, but it also indicates a potential value opportunity if the company can execute a margin recovery.
PE
10.1x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 8x~39x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
7.3x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: The primary risk is the severe and ongoing margin collapse, with gross margin plummeting from 22.1% to 14.4% year-over-year in Q4 2025. This indicates intense cost inflation and an inability to pass on price increases, directly threatening the company's earnings power. Furthermore, the company generated negative free cash flow of $81 million over the trailing twelve months, limiting its ability to invest or reduce its elevated debt-to-equity ratio of 1.67 without external financing. Revenue stagnation, with sequential declines from Q3 to Q4 2025, adds top-line pressure to an already compromised profitability profile.
Market & Competitive Risks: The stock's valuation, while discounted, may not be a sufficient margin of safety if earnings continue to deteriorate. Trading at a forward P/E of 9.6x, the market is pricing in low growth, but further earnings misses could lead to multiple compression. The stock has a low beta of 0.62, yet it has dramatically underperformed the market, suggesting company-specific, not systemic, risks are driving the decline. The limited analyst coverage (only 2 analysts) and recent downgrades highlight waning institutional confidence, which can lead to poor liquidity and heightened volatility.
Worst-Case Scenario: The worst-case scenario involves a continuation of the current negative trends: persistent margin pressure prevents a profitability recovery, leading to consecutive earnings misses and a breach of debt covenants. This could trigger further analyst downgrades, a dividend cut to preserve cash, and a loss of investor confidence. In this adverse scenario, the stock could retest and break below its 52-week low of $8.79, implying a further downside of approximately -22% from the current price of $11.26. A drawdown mirroring the stock's maximum historical drawdown of -65% is less likely but underscores the severity of the bear case.